Christopher T. Ritchlin, MD, MPH, discusses updated bimekizumab data from the BE-ACTIVE trial.

Yusuf Yazici, MD, discusses results from a trial evaluating a small molecule inhibitor of the Wnt pathway for the treatment of knee osteoarthritis.

Terence Rooney, MD, senior medical director, Lilly Bio-Medicines, discusses updated baricitinib safety data presented at ACR/ARHP 2018.

Megan Clowse, MD, MPH, discusses 2 studies that examine reproductive health concerns in women with inflammatory rheumatic diseases.

Allan Gibofsky, MD, discusses inhibition of the Wnt pathway and its potential benefits for the treatment of osteoarthritis.

This suggests to us that, as is the standard now, when we use an anabolic agent, we can add in an antiresorptive such as alendronate, and see continued sustained reduction in fracture risk.

Virginia Pascual, MD, discusses precision medicine for rheumatic diseases.

Machelle Manuel, PhD, discusses further gout treatment options to consider when target serum urate levels are not attained.

W. Benjamin Nowell, PhD, LMSW, discussed the importance of communication in family planning with female with patients who have rheumatoid arthritis.

A recent clinical trial has shown promising results that the drug febuxostat is effective at reducing gout flares in adults with early gout.

A cause for the lupus disease may have been identified as a protein by a researcher at the Feinstein Institute for Medical Research.

Lyme Disease is the most common tick-borne illness.

A recent study is providing evidence that recreational running is beneficial for hip and knee joint health.

Socioeconomic and racial disparities are linked in the severity and treatment of lupus.

Ultrasound imaging is more accurate, faster, and less painful than traditional X-rays for assessing the broken arms of children.

Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.

Dinesh Khanna, MD, MSc, discusses results of the open-label portion of a trial evaluating the safety and efficacy of placebo-treated patients with systemic sclerosis who were switched to received open-label tocilizumab.

John H. Stone, MD, MPH, discusses results from a phase 3, double-blind, randomized, controlled trial evaluating the efficacy of tocilizumab for the treatment of giant cell arteritis.

Gerd Burmester, MD,discusses results from the SARIL-RA-MONARCH trial.

Sarah Taber, MD, briefly reviews her ongoing research on genetic drivers of localized scleroderma in pediatric patients.

Kenneth Saag, MD, discusses new pooled safety data for lesinurad for the treatment of gout.

Researchers suggest that relapsing MPA and GPA and increased BMI were associated with increased glucocorticoid exposure following induction of remission.

Eric L. Matteson, MD, MPH, sat down with Rheumatology Advisor to discuss the morbidity associated with interstitial lung disease in RA.

W. Benjamin Nowell, PhD, LMSW, director of patient-centered research at Global Healthy Living Foundation and CreakyJoints, discusses the importance of shared decision making between patients and clinicians, and the development of a rheumatoid arthritis (RA) patient preference phenotype to guide clinical decision-making.

Nancy E. Lane, MD, professor of medicine, at the University of California at Davis School of Medicine, discusses results from the phase 3 ACTIVE trial.

Patient-reported outcomes have become a very important way to gain insight into outcomes of disease.

Video Transcript My name is Susan Goodman. I am a rheumatologist at the Hospital for Special Surgery (HSS) and my appointments are with Weill Cornell College of Medicine. My research interest is in the perioperative management of patients with rheumatic diseases, [and that is] what we’ve been doing here at HSS — managing both the…

Mary K. Crow, MD, discusses upcoming presentations at the ACR annual conference to be held November 11 – 16, in Washington, DC.

Michael M. Alexiades, MD, met with Rheumatology Advisor to discuss the surgical management of inflammatory arthritides.

Michael M. Alexiades, MD, met with Rheumatology Advisor to discuss the surgical management of inflammatory arthritides.